These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6875813)

  • 41. Application of hybrid approach based on empirical and physiological concept for predicting pharmacokinetics in humans--usefulness of exponent on prospective evaluation of predictability.
    Sayama H; Komura H; Kogayu M
    Drug Metab Dispos; 2013 Feb; 41(2):498-507. PubMed ID: 23209193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Constant-rate intravenous infusion methods for estimating steady-state volumes of distribution and mean residence times in the body for drugs undergoing reversible metabolism.
    Cheng H; Jusko WJ
    Pharm Res; 1990 Jun; 7(6):628-32. PubMed ID: 2367330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An estimation method of the clearance for a one-compartment model of a single bolus intravenous injection by a single sampling.
    Funatogawa T; Funatogawa I
    J Biopharm Stat; 2012; 22(1):43-53. PubMed ID: 22204526
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Model independent derivation of general equations for the "first-pass" effect and extra-hepatic drug elimination.
    Vaughan
    Eur J Clin Pharmacol; 1977; 11(1):57-64. PubMed ID: 832659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential errors in the volume of distribution estimation of therapeutic proteins composed of differently cleared components.
    Richter WF; Grimm HP; Theil FP
    J Pharmacokinet Pharmacodyn; 2011 Oct; 38(5):581-93. PubMed ID: 21779940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maintenance-dose prediction based on a single determination of concentration: dose of parent drug required to give a desired steady-state concentration of metabolite.
    Wilson JM; Slattery JT
    J Pharm Sci; 1983 Oct; 72(10):1174-8. PubMed ID: 6644567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Types of mean residence times.
    Wagner JG
    Biopharm Drug Dispos; 1988; 9(1):41-57. PubMed ID: 3342284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deciding on success criteria for predictability of pharmacokinetic parameters from in vitro studies: an analysis based on in vivo observations.
    Abduljalil K; Cain T; Humphries H; Rostami-Hodjegan A
    Drug Metab Dispos; 2014 Sep; 42(9):1478-84. PubMed ID: 24989891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LAGRAN program for area and moments in pharmacokinetic analysis.
    Rocci ML; Jusko WJ
    Comput Programs Biomed; 1983 Jun; 16(3):203-16. PubMed ID: 6688572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proceedings: Statistical considerations in the planning and analysis of pharmacokinetic experiments.
    Westlake WJ
    Acta Pharm Suec; 1974 Dec; 11(6):632. PubMed ID: 1136784
    [No Abstract]   [Full Text] [Related]  

  • 51. Improved Human Pharmacokinetic Prediction of Hepatically Metabolized Drugs With Species-Specific Systemic Clearance.
    Horiuchi K; Ohnishi S; Matsuzaki T; Funaki S; Watanabe A; Mizutare T; Matsumoto S; Nezasa KI; Hasegawa H
    J Pharm Sci; 2018 May; 107(5):1443-1453. PubMed ID: 29331382
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The area under the curve of metabolites for drugs and metabolites cleared by the liver and extrahepatic organs. Its dependence on the administration route of precursor drug.
    Klippert PJ; Noordhoek J
    Drug Metab Dispos; 1985; 13(1):97-101. PubMed ID: 2858385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New physiologically based methods for calculating the apparent steady-state volume of distribution in pharmacokinetic studies.
    Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):255-8. PubMed ID: 7107073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A three-compartment open model with first order absorption.
    Cherruault Y; Sarin VB
    Int J Biomed Comput; 1986 May; 18(3-4):273-81. PubMed ID: 3721608
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prediction of Tissue to Plasma Concentration Ratios of Drugs in the Rat from Experimentally Estimated Volume of Distribution: Application of Allometry.
    Mahmood I
    Curr Drug Metab; 2018; 19(2):155-164. PubMed ID: 29189141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Drug distribution in the body. I. Estimation of the kinetic rate and quantitation by statistical moments].
    LeBlanc PP; LeBel M
    J Pharm Belg; 1986; 41(2):69-74. PubMed ID: 3735052
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmacokinetics and their clinical significance.
    Garrett ER
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):193-6. PubMed ID: 5357862
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacokinetic transfer functions and generalized clearances.
    Siegel RA
    J Pharmacokinet Biopharm; 1986 Oct; 14(5):511-21. PubMed ID: 3806373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. On the accuracy of a one-compartment approach for determination of drug terminal half-life.
    Berezhkovskiy LM
    J Pharm Sci; 2013 Jul; 102(7):2082-4. PubMed ID: 23620272
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimal sampling times for minimum variance of clearance determination.
    Døssing M; Vølund A; Poulsen HE
    Br J Clin Pharmacol; 1983 Feb; 15(2):231-5. PubMed ID: 6849757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.